Castle Brands Inc.
Castle Brands Inc (Form: 10-Q, Received: 02/14/2008 17:26:31)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

[X]   Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended December 31, 2007

OR

[ ]   Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from              to             

Commission File Number 001-32849

CASTLE BRANDS INC.
(Exact name of registrant as specified in its charter)


Delaware 41-2103550
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
570 Lexington Avenue, 29th Floor,
New York, New York
10022
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (646) 356-0200

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes [X]     No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, accelerated filer or a non-accelerated filer (as defined in Rule 12b-2 of the Act). See definition of ‘‘accelerated filer and large accelerated filer’’ in Rule 12b-2 of the Exchange Act.


         [ ]    Large accelerated filer [ ]    Accelerated filer [X]    Non-accelerated filer

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes [ ]     No [X]

The Company had 15,629,776 shares of $0.01 par value common stock outstanding at February 13, 2008.





TABLE OF CONTENTS


PART I. FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements:  
  Condensed Consolidated Balance Sheets as of December 31, 2007 (unaudited) and March 31, 2007 1
  Condensed Consolidated Statements of Operations for the Three Months and Nine Months ended December 31, 2007 and 2006 (unaudited) 2
  Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Nine Months ended December 31, 2007 (unaudited) 3
  Condensed Consolidated Statements of Cash Flows for the Nine Months ended December 31, 2007 and 2006 (unaudited) 4
  Notes to Unaudited Condensed Consolidated Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 23
Item 3. Quantitative and Qualitative Disclosures About Market Risk 33
Item 4. Controls and Procedures 33
PART II. OTHER INFORMATION
Item 1. Legal Proceedings 35
Item 1A. Risk Factors 35
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 35
Item 3. Defaults Upon Senior Securities 35
Item 4. Submission of Matters to a Vote of Security Holders 35
Item 5. Other Information 35
Item 6. Exhibits 36
SIGNATURES    




PART I.    FINANCIAL INFORMATION

Item 1.    Condensed Consolidated Financial Statements

CASTLE BRANDS INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets


  December 31,
2007
March 31,
2007
  (Unaudited)  
ASSETS    
CURRENT ASSETS    
Cash and cash equivalents $ 791,063 $ 1,004,957
Short-term investments 7,171,374 5,912,464
Accounts receivable – net of allowance for doubtful accounts of $221,934 and $352,458 8,159,861 6,503,449
Due from affiliates 11,407 10,328
Inventories 10,156,765 10,716,983
Prepaid expenses and other current assets 1,531,829 1,585,901
TOTAL CURRENT ASSETS 27,822,299 25,734,082
EQUIPMENT – net 734,543 643,753
OTHER ASSETS    
Intangible assets – net of accumulated amortization of $2,464,676 and $2,233,808 13,769,977 13,813,596
Goodwill 12,495,287 13,036,650
Restricted cash 745,620 502,643
Other assets 560,697 795,237
TOTAL ASSETS $ 56,128,423 $ 54,525,961
LIABILITIES AND STOCKHOLDERS’ EQUITY  
CURRENT LIABILITIES    
Current maturities of notes payable and capital leases $ 3,824 $ 419,308
Accounts payable 3,644,858 5,150,535
Accrued expenses, put warrant payable and derivative instrument 1,809,495 1,987,669
Due to stockholders and affiliates 934,170 1,092,755
TOTAL CURRENT LIABILITIES 6,392,347 8,650,267
LONG TERM LIABILITIES    
Senior notes payable 9,575,547 9,354,861
Notes payable and capital leases, less current maturities 9,002,321 9,005,207
Deferred tax liability 2,444,254 2,555,368
TOTAL LIABILITIES 27,414,469 29,565,703
COMMITMENTS AND CONTINGENCIES (Note 15)    
MINORITY INTERESTS 302,378 1,407,645
STOCKHOLDERS’ EQUITY    
Preferred stock, $.01 par value, 5,000,000 shares authorized, none outstanding
Common stock, $.01 par value, 45,000,000 shares authorized; 15,629,776 and 12,109,741 shares issued and outstanding at December 31, and March 31, 2007, respectively 156,298 121,098
Additional paid in capital 104,480,522 84,086,710
Accumulated deficiency (74,505,799 )   (59,962,237 )  
Accumulated other comprehensive loss (1,719,445 )   (692,958 )  
TOTAL STOCKHOLDERS’ EQUITY 28,411,576 23,552,613
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 56,128,423 $ 54,525,961

See accompanying notes to the condensed consolidated financial statements.

1





CASTLE BRANDS INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(Unaudited)


  Three-months Ended
December 31,
Nine-months Ended
December 31,
  2007 2006 2007 2006
Sales, net $ 6,401,749 $ 7,380,605 $ 20,946,786 $ 19,093,072
Cost of sales 4,616,017 4,938,243 14,557,276 12,733,747
Allowance for obsolete and slow-moving inventory 1,707,035 1,707,035
Gross profit 78,697 2,442,362 4,682,475 6,359,325
Selling expense (Note 1L) 5,011,180 4,599,783 13,685,410 12,836,429
General and administrative expense (Note 1L) 2,072,462 2,101,331 6,224,491 6,235,824
Depreciation and amortization 236,150 262,926 791,851 743,214
Net operating loss (7,241,095 )   (4,521,678 )   (16,019,277 )   (13,456,142 )  
Other income 1,096 5,040
Other expense (19,255 )   (21,132 )   (40,719 )   (36,998 )  
Foreign exchange gain 144,454 483,799 1,304,389 1,143,588
Interest expense, net (392,919 )   (208,093 )   (1,193,733 )   (706,700 )  
Write-off of deferred financing costs in connection with conversion of 6% subordinated convertible notes (295,368 )  
Current credit on derivative financial instrument 132,255 189,397 121,397
Income tax benefit 37,038 37,033 111,114 111,109
Minority interests 613,877 366,208 1,105,267 1,101,422
Net loss $ (6,857,900 )   $ (3,730,512 )   $ (14,543,562 )   $ (12,012,652 )  
Preferred stock dividends 48,238
Net loss attributable to common stockholders $ (6,857,900 )   $ (3,730,512 )   $ (14,543,562 )   $ (12,060,890 )  
Net loss attributable to common stockholders per common share, basic and diluted $ (0.44 )   $ (0.31 )   $ (0.96 )   $ (1.02 )  
Weighted average shares used in computation, basic and diluted 15,629,776 12,051,045 15,141,981 11,827,837

See accompanying notes to the condensed consolidated financial statements.

2





CASTLE BRANDS INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Changes in Stockholders’ Equity
(Unaudited)


  Common Stock Additional
Paid in
Capital
Accumulated
Deficiency
Accumulated
Other
Comprehensive
Loss
Total
Stockholders’
Equity
 
  Shares Amount  
BALANCE, MARCH 31, 2007 12,109,741 $ 121,098 $ 84,086,710 $ (59,962,237 )   $ (692,958 )   $ 23,552,613  
Comprehensive loss              
Net loss       (14,543,562 )     (14,543,562 )    
Foreign currency translation adjustment         (1,026,487 )   (1,026,487 )    
Total comprehensive loss           (15,570,049 )    
Issuance of common stock in private placement, net of issuance costs 3,520,035 35,200 19,583,286     19,618,486  
Vesting of stock options as compensation     3,258     3,258  
Stock-based compensation     807,268     807,268  
BALANCE, DECEMBER 31, 2007 15,629,776 $ 156,298 $ 104,480,522 $ (74,505,799 )   $ (1,719,445 )   $ 28,411,576  

See accompanying notes to the condensed consolidated financial statements.

3





CASTLE BRANDS INC. and SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Unaudited)


  Nine-months Ended December 31,
  2007 2006
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (14,543,562 )   $ (12,012,652 )  
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 791,851 743,214
Change in provision for doubtful accounts 186,752 66,201
Minority interest in net loss of consolidated subsidiary (1,105,267 )   (1,101,422 )  
Loss on disposal of fixed assets 1,068
Write-off of deferred financing costs 484,369 390,756
Current (credit) on derivative financial instrument (189,397 )   (121,397 )  
Deferred tax benefit (111,114 )   (111,109 )  
Effect of changes in foreign currency rate (1,304,813 )   (997,604 )  
Stock-based compensation expense 807,268 1,057,396
Increase in allowance for obsolete inventories 1,681,293
Non-cash interest charge 283,727
Write-off of deferred financing costs in connection with conversion of 6% subordinated convertible notes 295,368
Changes in operations, assets and liabilities:    
Increase in accounts receivable (1,586,986 )   (4,938,326 )  
Increase in due from affiliates (92,715 )  
Increase in inventory (883,438 )   (2,607,467 )  
Decrease/(increase) in prepaid expenses and supplies 62,239 (198,592 )  
Increase in other assets (25,882 )   (139,590 )  
Decrease in accounts payable, accrued expenses, put warrant payable and derivative instrument (1,769,774 )   (58,528 )  
(Decrease)/increase in due to related parties (219,366 )   175,720
Total adjustments (3,181,197 )   (7,354,368 )  
NET CASH USED IN OPERATING ACTIVITIES (17,724,759 )   (19,367,020 )  
CASH FLOWS FROM INVESTING ACTIVITIES    
Acquisition of property and equipment (236,614 )   (221,631 )  
Acquisition of intangible assets (20,219 )   (129,144 )  
Business acquisitions – net of cash acquired (1,282,021 )  
Purchase of short-term investments (10,000,000 )  
Proceeds from sale of short-term investments 8,741,090
NET CASH USED IN INVESTING ACTIVITIES (1,515,743 )   (1,632,796 )  
CASH FLOWS FROM FINANCING ACTIVITIES    
Repayment of notes payable (16,173,044 )   (18,538,838 )  
Proceeds from notes payable and warrants 15,739,778 20,677,017
Payments of obligations under capital leases (2,745 )   (2,609 )  
Increase in restricted cash (179,800 )   (97,985 )  
Issuance of common stock 21,014,609 31,500,000
Payments for costs of stock issuances (1,396,123 )   (2,898,063 )  
NET CASH PROVIDED BY FINANCING ACTIVITIES 19,002,675 30,639,522
EFFECTS OF FOREIGN CURRENCY TRANSLATION 23,933 43
NET (DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS (213,894 )   9,639,749
CASH AND CASH EQUIVALENTS – BEGINNING 1,004,957 1,392,016
CASH AND CASH EQUIVALENTS – ENDING $ 791,063 $ 11,031,765
SUPPLEMENTAL DISCLOSURES    
Schedule of non-cash investing and financing activities:    
Conversion of redeemable convertible preferred stock, net of fractional shares, by issuance of common stock $ $ 28,447,667
Issuance of common stock in payment of accrued dividends $ $ 1,389,765
Conversion of 5% euro denominated convertible subordinated notes by issuance of common stock $ $ 1,663,173
Conversion of 40% of 6% convertible subordinated notes by issuance of common stock $ $ 6,000,000
Issuance of common stock $ $ 705,200
Interest paid $ 1,307,163 $ 1,000,963
Income taxes paid $ $

See accompanying notes to the condensed consolidated financial statements.

4





CASTLE BRANDS INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed consolidated financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with the rules and regulations of the Securities and Exchange Commission (‘‘SEC’’) and U.S. generally accepted accounting principles (‘‘GAAP’’) and in the opinion of management, contain all adjustments (which consist of only normal recurring adjustments) necessary for a fair presentation of such financial information. Results of operations for interim periods are not necessarily indicative of those to be achieved for full fiscal years. The Condensed Consolidated Balance Sheet as of March 31, 2007 is derived from the March 31, 2007 audited financial statements. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the fiscal year ended March 31, 2007 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.

A.   Description of business and business combination – Castle Brands Inc. is the successor to Great Spirits Company, LLC, a Delaware limited liability company (‘‘GSC’’). GSC was formed in February 1998. In May 2003, Great Spirits (Ireland) Limited (‘‘GSI’’), a wholly owned subsidiary of GSC, began operations in Ireland to market GSC’s products internationally. GSI had been an inactive entity since December 2003 and was dissolved as of September 30, 2006. In July 2003, GSRWB, Inc. (renamed Castle Brands Inc.) and its wholly owned subsidiary, Great Spirits Corp. (renamed Castle Brands (USA) Corp.) (‘‘CB-USA’’), were formed under the laws of Delaware in contemplation of a pending acquisition. On December 1, 2003, Castle Brands Inc. acquired The Roaring Water Bay Spirits Group Limited and The Roaring Water Bay Spirits Marketing and Sales Company Limited and their related entities (collectively, ‘‘Roaring Water Bay’’). The acquisition has been accounted for under purchase accounting. Simultaneously, GSC was merged into CB-USA, and Castle Brands Inc. issued stock to GSC’s members in exchange for their membership interests in GSC. Subsequent to the acquisition, The Roaring Water Bay Spirits Group Limited was renamed Castle Brands Spirits Group Limited (‘‘CB-IRL’’) and The Roaring Water Bay Spirits Marketing and Sales Company Limited was renamed Castle Brands Spirits Marketing and Sales Company Limited (‘‘CB-UK’’).

In February 2005, Castle Brands Inc. acquired 60% of the shares of Gosling-Castle Partners Inc. (‘‘GCP’’), which holds the worldwide distribution rights (excluding Bermuda) to Gosling’s rum and related products.

In October 2006, Castle Brands Inc. acquired all of the outstanding capital stock of McLain & Kyne, Ltd. (‘‘McLain & Kyne’’) pursuant to a Stock Purchase Agreement. McLain & Kyne is a Louisville, Kentucky based developer and marketer of three premium small batch bourbons: Jefferson’s Reserve, Jefferson’s and Sam Houston.

As used herein, the ‘‘Company’’ refers to Castle Brands Inc. and, where appropriate, it also refers collectively to Castle Brands Inc. and its direct and indirect subsidiaries, including its majority owned GCP subsidiary.

B.   Principles of consolidation – The consolidated financial statements include the accounts of Castle Brands Inc., its wholly-owned subsidiaries, CB-USA and McLain & Kyne, Castle Brands Inc.’s wholly-owned foreign subsidiaries, CB-IRL and CB-UK, and Castle Brands, Inc.’s majority owned subsidiary, GCP, with adjustments for income or loss allocated based upon percentage of ownership. The accounts of the subsidiaries have been included as of the date of acquisition. All significant intercompany transactions and balances have been eliminated.

5





C.   Organization and operations – The Company is principally engaged in the manufacture, marketing and sale of fine spirit brands of vodka, whiskey, rums and liqueurs (the ‘‘products’’) in the United States, Canada, Europe, and the Caribbean. Except for Gosling’s rums and the bourbon products, which are bottled in the United States, all of the Company’s products are imported from Europe. The vodka, Irish whiskies and certain liqueurs are produced by CB-IRL, billed in euros and imported into the United States. The risk of fluctuations in foreign currency is borne by the U.S. entities.
D.   Cash and cash equivalents – The Company considers all highly liquid instruments with a maturity date at acquisition of three-months or less to be cash and cash equivalents.
E.   Investments – The Company follows Statement of Financial Accounting Standards (‘‘SFAS’’) No. 115, Accounting for Certain Investments in Debt and Equity Securities, classifying its investments based on the intended holding period. The Company currently classifies its investments as available-for-sale. Available-for-sale securities are carried at estimated fair value, based on available market information, with unrealized gains and losses, if any, reported as a component of stockholders’ equity. Investments consist primarily of money market accounts and mutual funds that are highly liquid in nature and represent the investment of cash that is available for current operations. The mutual fund portfolio is composed of corporate debt, commercial paper, repurchase agreements, mortgage backed securities, commercial mortgage backed securities, bank obligations, asset backed commercial paper, and asset backed securities and had a net asset value of $1.00 per unit at December 31, 2007.
F.   Trade accounts receivable – The Company records trade accounts receivable at net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect anticipated losses on the trade accounts receivable balances. The Company calculates this allowance based on its history of write-offs, level of past due accounts based on contractual terms of the receivables and its relationships with, and economic status of, the Company’s customers.
G.   Revenue recognition – Revenue from product sales is recognized when the product is shipped to a customer (generally a distributor), title and risk of loss has passed to the customer in accordance with the terms of sale (FOB shipping point or FOB destination), and collection is reasonably assured. Revenue is not recognized on shipments to control states in the United States until such time as product is sold through to the retail channel.
H.   Inventories – Inventories, are comprised of distilled spirits, raw materials (bulk spirits, bottles, labels and caps), packaging and finished goods, and are valued at the lower of cost or market, using the weighted average cost method. The Company assesses the valuation of its inventories and reduces the carrying value of those inventories that are obsolete or in excess of the Company’s forecasted usage to their estimated net realizable value. The Company estimates the net realizable value of such inventories based on analyses and assumptions including, but not limited to, historical usage, expected future demand and market requirements. Reductions to the carrying value of inventories are recorded in cost of goods sold.

In December 2007 the Company recorded an allowance for obsolete and slow moving inventory of $1,707,035. This allowance was recorded on both raw materials and finished goods, primarily in the disposition of old packaging of Boru vodka, rendered obsolete with the repackaging in March 2007, and the old packaging of Clontarf Irish whiskey, rendered obsolete with the upcoming launch of the new Clontarf packaging in March 2008. The Company has reserved taking an allowance against the old Boru packaging in previous quarters as it was attempting to sell-off the old inventory in select markets. As of December 31, 2007 the new Boru packaging is available across all major markets and the Company does not foresee the ability to sell-off the old packaging in significant quantities. The allowance against the old Clontarf packaging has been recorded in the current quarter as production of the old packaging ended as of December 31, 2007 and the Company has

6





minimal finished product remaining. In addition, in an effort to refocus efforts on faster growing and more profitable SKUs and bottle sizes, the Company is reducing the number of both on some of it other products, primarily Gosling’s rums. The charge has been recorded as an increase to Cost of Sales in the current period.

I.   Goodwill and other intangible assets – Goodwill represents the excess of purchase price including related costs over the value assigned to the net tangible and identifiable intangible assets of businesses acquired. As of December 31, and March 31, 2007, goodwill and other indefinite lived intangible assets that arose from acquisitions were $12.5 million and $13.0 million, respectively. The change in the value of goodwill and other indefinite lived intangible assets is due to the completion of a third party valuation of intangible assets acquired in the McLain & Kyne acquisition versus initial estimated values. Goodwill and other identifiable intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or more frequently if circumstances indicate a possible impairment may exist. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to the estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The Company performed its annual impairment assessment on long-lived assets, including indefinite lived intangible assets and goodwill, and concluded that no impairment existed.
J.   Excise taxes and duty – Excise taxes and duty are computed at standard rates based on alcohol proof per gallon/liter and are paid after finished goods are imported into the United States and Great Britain and then transferred out of ‘‘bond.’’ Excise taxes and duty are recorded to inventory as a component of the cost of the underlying finished goods. When the underlying products are sold ‘‘ex warehouse’’ the sales price reflects the taxes paid and the inventoried excise taxes and duties are charged to cost of sales. Historically, the Company’s sales in Ireland have been made ‘‘in-bond’’, net of excise taxes. In September 2007, the Company made an initial sale to its new distributor in Ireland ‘‘ex-bond’’ that included $1,861,995 in excise taxes and VAT. These taxes are reflected in both the Company’s revenues and cost of sales as an equal increase to both. During the three-months and nine-months ended December 31, 2007 and 2006, the captions for the Company’s revenues and cost of sales included the amounts of excise tax and duties presented in the table below:

  Three-months ended
December 31,
Nine-months ended
December 31,
  2007 2006 2007 2006
Sales, net $ 869,035 $ 1,809,820 $ 5,197,091 $ 4,431,836
Cost of Sales $ 869,035 $ 1,809,820 $ 5,197,091 $ 4,431,836
K.   Foreign currency – The functional currency for the Company’s foreign operations is the euro in Europe, excluding the United Kingdom, where it is the British pound. The translation from the applicable foreign currencies to U.S. dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for revenue and expense accounts using a weighted average exchange rate during the period. The resulting translation adjustments are recorded as a component of other comprehensive income. Gains or losses resulting from foreign currency transactions are shown as a separate line item in accompanying consolidated statements of operations. As indicated in Note 1C, vodka, Irish whiskies and certain liqueurs are produced by CB-IRL and billed in euros to the U.S. entities, with the risk of foreign exchange gain/loss resting with CB-US. In addition, CBI has funded the continuing operations of the international subsidiaries. At each balance sheet date, the euro denominated intercompany balances included on the books of CB-IRL are restated in U.S. dollars at the exchange rate in effect at the balance sheet date, with the resulting foreign currency transaction gain or loss included in net income.
L.   Stock-based compensation – Incremental compensation expense for the three-months ended December 31, 2007 and 2006 amounted to $270,952 and $285,981, respectively, of which

7





  $115,417 and $136,604 are included in selling expense, respectively, and $155,535 and $149,377 are in general and administrative expense, respectively, in the accompanying condensed consolidated statements of operations. Incremental compensation expense for the nine-months ended December 31, 2007 and 2006 amounted to $807,268 and $1,057,396, respectively, of which $344,996 and $358,076 are included in selling expense, respectively, and $462,203 and $699,320 are in general and administrative expense, respectively, in the accompanying condensed consolidated statements of operations.
M.   Stock warrants – The Company accounted for the warrant and the registration rights penalty as a compound financial instrument in the consolidated financial statements at fair value following the guidelines of EITF 00-19, paragraphs 44 and 45, and paragraphs 11 and 24 of SFAS 150. Changes in the fair value of the compound instrument are recognized in earnings for each reporting period. For the three-months ended December 31, 2007 and 2006, the Company recorded a charge for the change in the value of the compound financial instrument of $0 and $8,666, respectively, and a (credit)/charge for the change in the value of the compound financial instrument of $(189,397) and $10,858, for the nine-months ended December 31, 2007 and 2006, respectively. Effective with the Company’s registration statement (Reg. no. 333-143422), as amended, filed with the SEC on June 29, 2007 and effective as of July 9, 2007, the registration rights penalty was reversed.
N.   Advertising – Advertising costs are expensed when the advertising first appears in its respective medium. Advertising expense, which is included in selling expense, for the three-months ended December 31, 2007 and 2006 was $949,500 and $946,124, respectively, and $2,721,523 and $3,475,024 for the nine-months ended December 31, 2007 and 2006, respectively.
O.   Use of estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates include the accounting for items such as evaluating annual impairment tests, stock-based compensation, allowance for doubtful accounts, inventory, depreciation, amortization and expense accruals.
P.   Recent accounting pronouncements – In September 2006, the Financial Accounts Standards Board (‘‘FASB’’) issued SFAS No. 157, ‘‘ Fair Value Measurements ,’’ to define fair value, establish a framework for measuring fair value in accordance with GAAP, and expand disclosures about fair value measurements. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007, the beginning of the Company’s 2009 fiscal year. In December 2007, the FASB released a proposed FASB Staff Position (FSP FAS 157b − Effective Date of FASB Statement No. 157 ) which, if adopted as proposed, would delay the effective date of SFAS No. 157 for all non-financial assets and non-financial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis (at last annually). The Company is assessing the impact the adoption of SFAS No. 157 will have on the Company’s financial position and results of operations.
    In February 2007, the FASB issued SFAS No. 159, ‘‘ The Fair Value Option for Financial Assets and Financial Liabilities ,’’ which allows an entity the irrevocable option to elect fair value for the initial and subsequent measurement for certain financial assets and liabilities on a contract-by-contract basis. Subsequent changes in fair value of these financial assets and liabilities would be recognized in earnings when they occur. SFAS 159 further establishes certain additional disclosure requirements. SFAS 159 is effective for fiscal years beginning after November 15, 2007, with earlier adoption permitted. Management is currently evaluating the impact and timing of the adoption of SFAS 159 on the Company’s consolidated financial statements.

8





On December 4, 2007, the FASB issued SFAS No. 141(R), ‘‘ Business Combinations ,’’ and SFAS No. 160, ‘‘ Accounting and Reporting of Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB No. 51 .’’ SFAS No. 141(R) is required to be adopted concurrently with SFAS No. 160 and is effective for business combination transactions for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. Early adoption is prohibited. Application of SFAS No. 141(R) and SFAS No. 160 is required to be adopted prospectively, except for certain provisions of SFAS No. 160, which are required to be adopted retrospectively. Business combination transactions accounted for before adoption of SFAS No. 141(R) should be accounted for in accordance with SFAS No. 141 and that accounting previously completed under SFAS No. 141 should not be modified as of or after the date of adoption of SFAS No. 141(R). The Company is currently evaluating the impact of SFAS No. 141(R) and SFAS No. 160, but does not expect the adoption of these pronouncements to have a material impact on the Company’s financial position or results of operations.

Q.   Reclassifications – Certain prior year balances have been reclassified to conform to the current period classification.

NOTE 2 — BASIC AND DILUTED NET LOSS PER COMMON SHARE

Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed giving effect to all dilutive potential common shares that were outstanding during the period. Diluted potential common shares consist of incremental shares issuable upon exercise of stock options and warrants and contingent conversion of debentures. In computing diluted net loss per share for the nine-months ended December 31, 2007 and 2006, no adjustment has been made to the weighted average outstanding common shares as the assumed exercise of outstanding options and warrants and the assumed conversion of convertible debentures is anti-dilutive.

Potential common shares not included in calculating diluted net loss per share are as follows:


  December 31,
2007
December 31,
2006
Stock options 1,557,625 1,428,500
Stock warrants 2,305,432 812,218
Convertible debentures 1,192,380 1,125,000
Total 5,055,437 3,365,718

NOTE 3 — INVESTMENTS

The following is a summary of available-for-sale securities:


  Estimated
Fair Value
December 31, 2007  
Money Market Accounts $ 2,022,410
Mutual fund 5,148,964
Total $ 7,171,374

The cost of the Company’s short-term investments approximates their fair-values.

9





NOTE 4 — INVENTORIES


  December 31,
2007
March 31,
2007
Raw materials $ 2,357,276 $ 1,501,455
Finished goods 7,799,489 9,215,528
Total $ 10,156,765 $ 10,716,983

As of December 31, and March 31, 2007, 78.6% and 99.1%, respectively, of the raw materials and 5.1% and 13.0%, respectively, of finished goods were located outside of the United States.

Inventories are stated at the lower of weighted average cost or market, and are shown net of an allowance for obsolete and slow moving inventory of $1,707,035 and $261,000 at December 31, and March 31, 2007, respectively.

NOTE 5 — INTANGIBLE ASSETS

Intangible assets consist of the following:


  December 31,
2007
March 31,
2007
Definite life brands $ 300,944 $ 308,909
Trademarks 478,073 408,222
Rights 9,036,793 9,036,793
Patents 994,000 825,000
Distribution relationships 416,000
Supply relationships 732,000 732,000
Other 28,480 28,480
  11,570,290 11,755,404
Less: accumulated amortization 2,464,676 2,233,808
Net 9,105,614 9,521,596
Other identifiable intangible assets – indefinite life trade names and formulations 4,664,363 4,292,000
  $ 13,769,977 $ 13,813,596

Accumulated amortization consists of the following:


  December 31,
2007
March 31,
2007
Definite life brands $ 243,329 $ 230,992
Trademarks 58,176 25,790
Rights 1,634,054 1,220,093
Patents 230,217 183,333
Distribution relationship 329,600
Supply relationships 298,900 244,000
Accumulated amortization $ 2,464,676 $ 2,233,808

Amortization expense for the three-months ended December 31, 2007 and 2006 totaled $188,046 and $219,463, respectively, and $646,868 and $621,465 for the nine-months ended December 31, 2007 and 2006, respectively.

On September 1, 2006, the Company delivered notice to a certain distributor that it was terminating its distribution agreement. As a result of the delivery of the notice, the distribution agreement has been terminated, as provided for by its terms, as of September 15, 2007. The Company has adjusted the estimated useful life of the underlying intangible asset to agree with the termination date.

10





Estimated aggregate amortization expense for each of the five succeeding years is as follows:


For the years ending December 31, Amount
2008 $ 784,211
2009 784,211
2010 784,211
2011 784,211
2012 784,211
Total $ 3,921,055

NOTE 6 — RESTRICTED CASH

The Company has cash collateral on deposit for creditors insurance in Ireland of €506,243, or $745,620 (as translated at the exchange rate in effect on December 31, 2007).

NOTE 7 — OVERDRAFT ACCOUNTS

CB-IRL and CB-UK maintain overdraft coverage with a financial institution in Ireland of up to €400,000 ($589,140) and £20,000 ($39,975), respectively. Overdraft balances included in notes payable totaled $0 and $380,334 at December 31, and March 31, 2007, respectively.

NOTE 8 — SENIOR NOTES PAYABLE, NOTES PAYABLE AND CAPITAL LEASES


  December 31,
2007
March 31,
2007
Notes payable consist of the following:    
Revolving credit facilities $ $ 407,261
Revolving credit facilities 8,363
Senior notes payable 9,575,547 9,354,861
Subordinated convertible notes 9,000,000 9,000,000
  18,575,547 18,770,485
Capital leases 6,145 8,891
Total $ 18,581,692 $ 18,779,376

Principal payments due over the next five years for the above listed notes payable and capital leases are as follows (as translated at the exchange rate in effect on December 31, 2007):


For the years ending December 31,  
2008 $ 3,824
2009 9,577,868
2010 9,000,000
Total 18,581,692
Less current portion 3,824
Non current portion $ 18,577,868

NOTE 9 — COMMON STOCK

Unregistered Sales of Equity Securities – On April 18, 2007, the Company entered into a Securities Purchase Agreement (the ‘‘Securities Purchase Agreement’’) with selected investors (each an ‘‘Investor’’ and collectively, the ‘‘Investors’’). Pursuant to the terms of the Securities Purchase Agreement, the Company has sold in a private placement a total of 3,520,035 shares of its common stock, (the ‘‘Common Stock’’), for aggregate gross proceeds of $21,014,609. Net proceeds to the Company after offering costs were $19,618,484. The transaction closed on May 8, 2007. The Investors included, among others, Frederick M. R. Smith and Phillip Frost, MD, each a director of the Company, and CNF Investments II, LLC, of which Robert J. Flanagan, a director of the Company, is a manager.

11





As part of the transaction, investors received warrants to purchase approximately 1,408,014 additional shares at an exercise price of $6.57 per share (the ‘‘Warrants’’). The Warrants will remain exercisable for a period of five years from the closing of the offering. The Warrants contain anti-dilution protection for stock splits and similar events, but do not contain any price-based anti-dilution adjustments. In connection with the transaction, Piper Jaffray & Co., as placement agent was issued a warrant to purchase 35,200 shares of Common Stock at an exercise price of $5.97 per share, exercisable within five years following the issuance of the warrant (the ‘‘Agent Warrant’’). The Agent Warrant is otherwise on the same terms and conditions as the Warrants.

Registration Rights Agreement – On April 18, 2007, the Company entered into a Registration Rights Agreement (the ‘‘Registration Rights Agreement’’) with the Investors. Pursuant to the Registration Rights Agreement, the Company has agreed to register the resale of the shares of Common Stock sold to the Investors pursuant to the Securities Purchase Agreement, including the shares issuable upon exercise of the Warrants. The Company agreed to file with the SEC a registration statement with respect to this registration within 30 days after closing. The Company filed such registration statement on May 31, 2007, within this 30 day timeframe. The registration statement was declared effective as of July 9, 2007.

NOTE 10 — FOREIGN CURRENCY FORWARD CONTRACTS

The Company enters into forward contracts to attempt to limit its exposure to foreign currency fluctuations. The Company recognizes in the balance sheet derivative contracts at fair value, and reflects any net gains and losses currently in earnings. At December 31, 2007, the Company held outstanding forward exchange positions for the purchase of euros, expiring through February 2008, in the amount of $590,720 with a weighted average conversion rate of €1 = $1.4768 as compared to the spot rate at December 31, 2007 of €1 = $1.4728. Gain or loss on foreign transactions related to the foreign currency forward contracts, which was de minimis, is included in other income and expense.

NOTE 11 — PROVISION FOR INCOME TAXES

On January 1, 2007, the Company adopted the provisions of FIN 48 – ‘‘ Accounting for Uncertainty in Income Taxes – an interpretation of FASB Statement No. 109 ’’. FIN 48 clarifies and sets forth consistent rules for accounting for uncertain tax positions in accordance with FAS 109, ‘‘ Accounting for Income Taxes .’’

As a result of the implementation of FIN 48, the Company made a review of its portfolio of uncertain tax positions in accordance with recognition standards established by FIN 48.  In this regard, an uncertain tax position represents the Company’s expected treatment of a tax position taken in a filed tax return, or planned to be taken in a future tax return, that has not been reflected in measuring income tax expense for financial reporting purposes. As a result of this review, the Company determined that it had no material uncertain tax positions and, therefore, it has not recorded unrecognized tax benefits. The Company does not expect any material changes to its uncertain tax positions.

The tax years 2005 through 2007 remain open to examination by federal and state tax jurisdictions.

The Company has various foreign subsidiaries for which tax years 2001 through 2007 remain open to examination in certain foreign tax jurisdictions.

The Company’s income tax benefit for the three-months and nine months ended December 31, 2007 and 2006 consists of federal and state and local taxes attributable to GCP which does not file a consolidated income tax return with the Company. In connection with the investment in GCP, the Company recorded a deferred tax liability on the ascribed value of the acquired intangible assets of $2,222,222, increasing the value of the asset. The deferred tax liability is being reversed and a deferred tax benefit is being recognized over the amortization period of the intangible asset (15 years). For the three-months ended December 31, 2007 and 2006, the Company recognized $37,038 and $37,033 of deferred tax benefits, respectively, and $111,114 and $111,109 for the nine-months ended December 31, 2007 and 2006, respectively.

12





On December 1, 2003, the Company recorded a deferred tax liability of $629,444 as the amount ascribed to the difference between the book and tax basis of the tangible and intangible assets acquired as additional goodwill.

Pursuant to FIN 48, the Company recognizes interest and penalties related to uncertain tax positions in the provision for income taxes. The Company did not recognize any such interest and/or penalties during the nine-months ended December 31, 2007 and 2006.

NOTE 12 — STOCK OPTIONS AND WARRANTS

A.   Stock Options – In July 2003, the Company implemented the 2003 Stock Incentive Plan (the ‘‘Plan’’) which provides for awards of incentive and non-qualified stock options, restricted stock and stock appreciation rights for its officers, employees, consultants and directors in order to attract and retain such individuals who contribute to the Company’s success by their ability, ingenuity and industry knowledge, and to enable such individuals to participate in the long-term success and growth of the Company by giving them an equity interest in the Company. There are 2,000,000 common shares reserved and available for distribution under the Plan, of which 442,375 remain available. Stock options granted under the Plan are granted with an exercise price at or above the fair market value of the underlying common stock at the date of grant, generally vest over a four or five year period and expire ten years after the grant date.

At December 31, 2007, total unrecognized compensation cost amounted to approximately $2,069,333, representing 858,925 of unvested options. There were no options exercised under the share-based payment arrangements during the nine-months ended December 31, 2007 and 2006.

The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model and is affected by assumptions regarding a number of highly complex and subjective variables. The use of an option pricing model also requires the use of a number of complex assumptions, including expected volatility, risk-free interest rate, expected dividends, and expected term. Expected volatility is based on the historical volatility of a peer group of companies over the expected life of the option as the Company does not have enough history trading as a public company to calculate its own stock price volatility. The expected term and vesting of the options represents the estimated period of time until exercise and is based on historical experience of similar awards, giving consideration to the contractual terms, vesting schedules and expectations of future employee behavior. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option. The Company has not paid dividends in the past and does not plan to pay any dividends in the near future. SFAS 123R also requires the Company to estimate forfeitures at the time of grant and revise these estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company estimates forfeitures based on its expectation of future experience while considering its historical experience.

13





A summary of the options outstanding under the Plan is as follows:


  Nine-months ended December 31,  
  2007 2006  
  Shares Weighted
Average
Exercise
Price
Shares Weighted
Average
Exercise
Price
 
Outstanding at beginning of period 1,294,125 $ 7.19 888,500 $ 6.82  
Granted 298,500 3.71 540,000 8.18  
Forfeited (35,000 )   6.51  
Outstanding at end of period 1,557,625 6.54 1,428,500 7.09  
Options exercisable at period end